Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic peptide-based antiviral vaccine for mass immunization in i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryzhikov, Alexander B., Ryzhikov, Evgeny A., Bogryantseva, Marina P., Usova, Svetlana V., Nechaeva, Elena A., Danilenko, Elena D., Pyankov, Stepan A., Gudymo, Andrey S., Moiseeva, Anastasiya A., Onkhonova, Galina S., Pyankov, Oleg V., Sleptsova, Ekaterina S., Lomakin, Nikita V., Vasilyeva, Veronika S., Tulikov, Mikhail V., Gusarov, Vitaly G., Pulin, Andrey A., Balalaeva, Maria A., Erofeeva, Svetlana B., Terpigorev, Stanislav A., Rychkova, Olga A., Petrov, Ivan M., Delian, Viktoriia Y., Rafalskiy, Vladimir V., Tyranovets, Sergey V., Gavrilova, Elena V., Maksyutov, Rinat A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222305/
https://www.ncbi.nlm.nih.gov/pubmed/37243102
http://dx.doi.org/10.3390/vaccines11050998

Ejemplares similares

Ejemplares similares